Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations 2015, Kilitch Drugs (India) has informed that Board of Directors in their meeting held on May 9, 2017 had approved the change in designation of Syed Azizur Rahman from Non-executive Director to Executive Director (Whole Time Director) of the company with effect from May 9, 2017.
The above information is a part of company’s filings submitted to BSE.